The UK’s largest pharmacy, Alliance Boots, is reportedly set to face significant antitrust scrutiny should it proceed with a full acquisition of Co-op Group’s pharmacies.
Lawyers cautioned that the Competition and Markets Authority would likely require asset sales to approve of the acquisition. Co-op announced earlier this year that it plans to divest hundreds of pharmacies. Several interested bidders, most of which are private equity groups, have already emerged, reports say
But Alliance Boots has also eyed the assets but experts believe the deal would not likely succeed.
Full content: The Telegraph
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Biden Administration Unveils Measures to Tackle Healthcare Costs Through Competition
Dec 7, 2023 by
CPI
Australia’s to Probe Coles and Woolworths for Alleged Price Gouging
Dec 7, 2023 by
CPI
D.C. Attorney General Pushes to Revive Suit Accusing Amazon of Price-Fixing
Dec 7, 2023 by
CPI
Google Withdraws Appeal, Opening the Door for Indian Startups Against User Choice Billing System
Dec 7, 2023 by
CPI
U.S. Congress Delays Legislation on TikTok Amid National Security Concerns
Dec 7, 2023 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Horizontal Competition: Mergers, Innovation & New Guidelines
Nov 30, 2023 by
CPI
Innovation in Merger Control
Nov 30, 2023 by
CPI
Making Sense of EU Merger Control: The Need for Limiting Principles
Nov 30, 2023 by
CPI
Sustainability Agreements in the EU: New Paths to Competition Law Compliance
Nov 30, 2023 by
CPI
Merger Control and Sustainability: A New Dawn or Nothing New Under the Sun?
Nov 30, 2023 by
CPI